Considering that GILZ is also involved in the pathophysiology of IBD, as demonstrated in both preclinical models of colitis and in patients, in this study, we investigated the effects of combining GILZp with a potential prebiotic yeast extract (Py) in a mouse model of colitis. This evidence concerns the gene TSC22D3 and inflammatory bowel disease.